1. Home
  2. DFLI vs ELUT Comparison

DFLI vs ELUT Comparison

Compare DFLI & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dragonfly Energy Holdings Corp. (NV)

DFLI

Dragonfly Energy Holdings Corp. (NV)

HOLD

Current Price

$1.92

Market Cap

49.0M

Sector

Technology

ML Signal

HOLD

ELUT

Elutia Inc.

N/A

Current Price

$1.01

Market Cap

48.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFLI
ELUT
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.0M
48.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DFLI
ELUT
Price
$1.92
$1.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.25
$6.00
AVG Volume (30 Days)
362.4K
62.8K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
0.87
Revenue
N/A
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$51.17
$10.83
P/E Ratio
N/A
$1.15
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.50
52 Week High
$5.15
$2.60

Technical Indicators

Market Signals
Indicator
DFLI
ELUT
Relative Strength Index (RSI) 42.82 39.03
Support Level $1.56 $1.00
Resistance Level $2.24 $1.18
Average True Range (ATR) 0.15 0.06
MACD 0.02 -0.02
Stochastic Oscillator 5.37 4.87

Price Performance

Historical Comparison
DFLI
ELUT

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: